MedTrace Logo

Comparison of Alendronate With Atorvastatin in Chronic Periodontitis

NCT02455869 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 104

Last updated 2015-05-28

No results posted yet for this study

Summary

The present study is designed as a single-centre, randomized, controlled clinical trial to evaluate and compare the clinical efficacy of two local drug delivery systems containing 1% ALN gel and 1.2% ATV gel in treatment of intrabony defects in patients with chronic periodontitis as an adjunct to SRP.

Conditions

  • Chronic Periodontitis

Interventions

DRUG

SRP and Placebo gel

After SRP, placebo gel was delivered subgingivally into the pocket

DRUG

SRP and Atorvastatin

After SRP, Atorvastatin gel was delivered subgingivally into the pocket

DRUG

SRP and Alendronate

After SRP, Alendronate gel was delivered subgingivally into the pocket

Sponsors & Collaborators

  • Government Dental College and Research Institute, Bangalore

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2015-03-31
Completion
2015-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02455869 on ClinicalTrials.gov